Rohit K. Singla will discuss the ethical implications of the Federal Circuit’s recent Therasense ruling on the inequitable conduct doctrine. Mr. Singla is a speaker at the Intellectual Property Owners Association Annual Meeting, which is being held Sept. 11-13 in Los Angeles.
Mr. Singla was lead appellate counsel in obtaining en banc review of the inequitable conduct doctrine before the Federal Circuit. The full panel’s May 2011 ruling marked a sea change in how patent cases are litigated by changing the standards in determining inequitable conduct before the U.S. Patent and Trademark Office. As many as 80 percent of patent infringement cases include inequitable conduct allegations, according to the ruling.
Mr. Singla will participate as part of a Sept. 13 panel discussion that will also include insight from Raymond Chen of the U.S. Patent & Trademark Office, James J. Kelley of Eli Lilly and attorney B. Jim Badke.
Mr. Singla is a litigation partner in the San Francisco office of Munger, Tolles & Olson. His practice focuses on antitrust and intellectual property issues in high-technology sectors, Mr. Singla has represented clients in a broad range of industries and technologies, including software, entertainment, videogames, pharmaceutical and medical devices.